Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

ClinicalTrials.gov ID: NCT01371734

Public ClinicalTrials.gov record NCT01371734. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 5:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study To Evaluate The Efficacy, Safety And Tolerability Of Desvenlafaxine Succinate Sustained-release (Dvs Sr) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a double-blind study evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) versus placebo in the Treatment of Children and Adolescent Outpatients with Major Depressive Disorder (MDD).

Study identification

NCT ID
NCT01371734
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
363 participants

Conditions and interventions

Eligibility (public fields only)

Age range
7 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2011 (Type not available)
Primary completion
Sep 2015 (Actual)
Completion
Sep 2015 (Actual)
Last update posted
Mar 20, 2017

2011 – 2015

United States locations

U.S. sites
39
U.S. states
20
U.S. cities
33
Facility City State ZIP Site status
Children's Hospital of Alabama Laboratory Birmingham Alabama 35233 —
The University of Alabama at Birmingham, Office of Psychiatric Research Birmingham Alabama 35294 —
Center for Advanced Improvement Tucson Arizona 85719 —
Sun Valley Research Center Imperial California 92251 —
MCB Clinical Research Centers Colorado Springs Colorado 80910 —
Bliss Basement Pharmacy - Hartford Hospital Hartford Connecticut 06102 —
Institute of Living/Hartford Hospital Hartford Connecticut 06106 —
Institute of Living Hartford Connecticut 06106 —
SJS Clinical Research, Inc. Destin Florida 32541 —
Sarkis Clinical Trials Gainesville Florida 32607 —
Clinical Neuroscience Solutions Jacksonville Florida 32256 —
Medical Research Group of Central Florida Orange City Florida 32763 —
Millenia Psychiatry & Research, Inc. Orlando Florida 32839 —
Janus Center for Psychiatric Research West Palm Beach Florida 33407 —
Northwest Behavioral Research Center Marietta Georgia 30060 —
Capstone Clinical Research Libertyville Illinois 60048 —
AMR-Baber Research Inc. Naperville Illinois 60563 —
Clinco Terre Haute Indiana 47802 —
Louisiana State University Health Sciences Center-Psychopharmacology Research Clinic Shreveport Louisiana 71103 —
Drug:University Health Shreveport Outpatient Shreveport Louisiana 71130 —
Pharmasite Research Inc Baltimore Maryland 21208 —
Millennium Psychiatric Associates, LLC Creve Coeur Missouri 63141 —
Premier Psychiatric Research Institute, LLC Lincoln Nebraska 68526 —
Erie County Medical Center / State University of New York at Buffalo affiliate Buffalo New York 14215 —
The Zucker Hillside Hospital, North Shore-Long Island Jewish Health System Glen Oaks New York 11004 —
Bioscience Research, LLC. Mount Kisco New York 10549 —
Finger Lakes Clinical Research Rochester New York 14618 —
Stony Brook University Medical Center, Child And Adolescent Psychiatry Stony Brook New York 11794-8790 —
Neuro-Behavioral Clinical Research, Inc. Canton Ohio 44718 —
Discovery and Wellness Center for Children/University Hospitals Case Medical Center Cleveland Ohio 44106 —
Sooner Clinical Research Oklahoma City Oklahoma 73112 —
Research Strategies of Memphis, LLC. Memphis Tennessee 38119 —
FutureSearch Trials Austin Texas 78731 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Alliance Research Group Richmond Virginia 23230 —
Virginia Commonwealth University Richmond Virginia 23298 —
Virginia Treatment Center Richmond Virginia 23298 —
Carilion Medical Center Roanoke Virginia 24014 —
Eastside Therapeutic Resource Kirkland Washington 98033 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01371734, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 20, 2017 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01371734 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →